Home > News > Biotechnology companies learn how to attract more VC
March 17th, 2005
Biotechnology companies learn how to attract more VC
Christopher Anzalone, founder and CEO of The Benet Group in Washington, D.C., said the investment group looks for promising technology over all else. Nanotechnology looks particularly promising, with the federal government putting upward of a billion dollars into nanotech research annually.
But Bonsal said using public money to finance nanotech is probably premature. He cited NanoInk, a Chicago company formerly headed by Anzalone, which issued an initial public offering only to later withdraw it due to lack of interest. "There's capital," Anzalone said. "What's missing is good companies."
TARA Biosystems and Harris & Harris Group Form Company to Improve Safety and Efficacy of New Therapies October 22nd, 2014
Arrowhead Issues Open Letter to Shareholders October 9th, 2014
PEN Inc. Announces New Trading Symbol: PENC: Stock Continues Trading on the OTCQB September 3rd, 2014
Aspen Aerogels, Inc. to Present at Barclays CEO Energy-Power Conference August 27th, 2014